Wednesday, March 25, 2026 | 12:02 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 2497 - Markets News

Emami Q2 pre-tax profit up 11%, misses street forecast due to slowdown

20% growth in international business helps firm post overall revenue growth, firm's brands improve market share despite tepid offtake

Emami Q2 pre-tax profit up 11%, misses street forecast due to slowdown
Updated On : 06 Nov 2019 | 9:45 PM IST

Market Wrap, Nov 4: Bulls make a comeback, Sensex closes at record high

Buying in private banks and IT major Infosys propelled the benchmark S&P BSE Sensex to end at a record closing peak of 40,469.78, up 222 points or 0.55 per cent on Wednesday

Market Wrap, Nov 4: Bulls make a comeback, Sensex closes at record high
Updated On : 06 Nov 2019 | 5:25 PM IST

Nilekani assures action if whistleblower allegations proved; Infosys up 2%

Backing Parekh, the chairman of the IT bellwether said that he would give full credit to the CEO for the company's growth.

Nilekani assures action if whistleblower allegations proved; Infosys up 2%
Updated On : 06 Nov 2019 | 4:48 PM IST
MARKET WRAP: Sensex ends at new closing high of 40,469.78; pvt banks rally
Updated On : 06 Nov 2019 | 4:42 PM IST

Varun Beverages zooms 26% in three days on healthy Q3 results

The company reported robust volume growth as domestic organic growth up by 17.5 per cent and internationally it grew 27 per cent.

Varun Beverages zooms 26% in three days on healthy Q3 results
Updated On : 06 Nov 2019 | 1:37 PM IST

Aurobindo Pharma trades near 52-wk low as Hyd units come under US FDA lens

The management believes that these observations are related to procedural improvements and none of the observations are related to data integrity.

Aurobindo Pharma trades near 52-wk low as Hyd units come under US FDA lens
Updated On : 06 Nov 2019 | 12:52 PM IST

Equity schemes see 2nd highest inflows in Aug

Equity schemes see 2nd highest inflows in Aug

Image
Updated On : 06 Nov 2019 | 11:37 AM IST

Sun Pharma climbs over 5% on deal with AstraZeneca, pares gains later

The agreement will be announced later in the day at the China International Import Expo (CIIE) in Shanghai.

Sun Pharma climbs over 5% on deal with AstraZeneca, pares gains later
Updated On : 06 Nov 2019 | 11:06 AM IST

SRF rallies 5%, hits new high post strong Q2 results, capex plan

The management said the specialty chemicals business performed well with strong demand witnessed in the overseas markets.

SRF rallies 5%, hits new high post strong Q2 results, capex plan
Updated On : 06 Nov 2019 | 10:56 AM IST

Sobha, Indiabulls Real Estate gain up to 5% as FM hints at booster dose

The real estate sector has been struggling for the last three years and has not revived since demonetisation and the introduction of good and services tax (GST).

Sobha, Indiabulls Real Estate gain up to 5% as FM hints at booster dose
Updated On : 06 Nov 2019 | 10:06 AM IST

Titan plunges 10% on disappointing Q2 nos, cut in H2FY20 revenue guidance

Profit before tax (PBT) stood at Rs 429 crore, down 3.7 per cent year-on-year (YoY) and net profit was up just 1.8 per cent YoY to Rs 320 crore.

Titan plunges 10% on disappointing Q2 nos, cut in H2FY20 revenue guidance
Updated On : 06 Nov 2019 | 9:59 AM IST

Stocks to watch: Realty stocks, Lupin, Tata Steel, Tech Mahindra, Titan Co

Here's a list of stocks that may trade actively in today's trading session.

Stocks to watch: Realty stocks, Lupin, Tata Steel, Tech Mahindra, Titan Co
Updated On : 06 Nov 2019 | 9:05 AM IST

PNB slips over 6% as asset quality worsens in Q2, provisions rise 5% QoQ

The public sector lender's slippages jumped 38 per cent sequentially from Rs 5,412 crore reported in Q1FY20 to Rs 7,460 crore in the quarter under review, the bank's management said.

PNB slips over 6% as asset quality worsens in Q2, provisions rise 5% QoQ
Updated On : 06 Nov 2019 | 8:44 AM IST

Market Ahead, November 6: All you need to know before the Opening Bell

Exide Industries, Cipla, Voltas, Tata Steel, and 75 other companies are scheduled to announce their September quarter results today

Market Ahead, November 6: All you need to know before the Opening Bell
Updated On : 06 Nov 2019 | 8:09 AM IST

Technical calls by Religare Broking: Buy Dr Reddy's Lab, Ramco Cements

Weekly Technical Recommendations by Religare Broking Ltd.

Technical calls by Religare Broking: Buy Dr Reddy's Lab, Ramco Cements
Updated On : 06 Nov 2019 | 7:53 AM IST

Technical calls by HDFC Securities: Buy Jubilant Foodworks, TCI Express

Technical calls from Vinay Rajani, Technical & Derivatives Analyst, HDFC securities.

Technical calls by HDFC Securities: Buy Jubilant Foodworks, TCI Express
Updated On : 06 Nov 2019 | 7:33 AM IST

Cadila growth may take a hit as Moraiya facility comes under USFDA radar

Krishnanath Munde at Reliance Securities says he does not expect any new drug approval from the facility till it gets regulatory clearance.

Cadila growth may take a hit as Moraiya facility comes under USFDA radar
Updated On : 06 Nov 2019 | 2:23 AM IST

NSE seeks cut in tax on capital market transactions to boost investment

Vikram Limaye said several taxes, including the securities transaction tax and the goods and services tax, are hurting investor participation

NSE seeks cut in tax on capital market transactions to boost investment
Updated On : 06 Nov 2019 | 1:57 AM IST

High gold prices, soft jewellery demand weigh on Titan's Q2 performance

Topline was flat aided by higher gold prices amidst 14% fall in volumes, PBT was down 3.7%; stock could see some pressure

High gold prices, soft jewellery demand weigh on Titan's Q2 performance
Updated On : 06 Nov 2019 | 1:48 AM IST

Offshore derivatives: Sebi eases guidelines for hedging instruments

The eligibility norms for NRIs/OCIs, however, have been retained according to the erstwhile circular.

Offshore derivatives: Sebi eases guidelines for hedging instruments
Updated On : 06 Nov 2019 | 1:11 AM IST